HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiro Nomura Selected Research

FK 224

2/2002Involvement of thromboxane A(2) in airway mucous cells in asthma-related cough.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akihiro Nomura Research Topics

Disease

13Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2021 - 01/2016
12Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2012
10Coronary Artery Disease (Coronary Atherosclerosis)
02/2022 - 12/2012
10Inflammation (Inflammations)
01/2007 - 02/2002
8Asthma (Bronchial Asthma)
01/2018 - 02/2002
7Sitosterolemia
08/2021 - 08/2018
6Acute Coronary Syndrome
05/2022 - 07/2018
5Stroke (Strokes)
01/2020 - 05/2013
5Chronic Obstructive Pulmonary Disease (COPD)
01/2007 - 04/2005
4Essential Hypertension
10/2022 - 01/2020
4Hypercholesterolemia
06/2022 - 01/2016
4Myocardial Infarction
01/2022 - 05/2013
4Hypertension (High Blood Pressure)
10/2021 - 11/2018
4Peripheral Arterial Disease
10/2020 - 01/2018
4Coronary Disease (Coronary Heart Disease)
01/2019 - 12/2016
3Cardiac Arrhythmias (Arrythmia)
02/2022 - 09/2020
3Heart Failure
01/2022 - 12/2016
3Xanthomatosis (Xanthoma)
08/2021 - 09/2018
3Neoplasms (Cancer)
10/2020 - 01/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 09/2013
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
09/2020 - 02/2016
3Type 2 Diabetes Mellitus (MODY)
06/2019 - 01/2018
2Unstable Angina
01/2022 - 01/2020
2COVID-19
09/2021 - 07/2021
2Inborn Genetic Diseases (Disease, Hereditary)
08/2021 - 01/2019
2Fibrosis (Cirrhosis)
05/2021 - 07/2006
2Death (Near-Death Experience)
01/2020 - 12/2012
2Hypobetalipoproteinemias (Hypobetalipoproteinemia)
01/2020 - 01/2019
2Thromboembolism
01/2019 - 01/2018
2Autoimmune Diseases (Autoimmune Disease)
11/2018 - 06/2017
2Diabetes Mellitus
11/2018 - 05/2013
2Ventricular Tachycardia
10/2017 - 02/2017
2Hyperplasia
04/2007 - 07/2006
2Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2006 - 05/2004
2Emphysema
12/2005 - 11/2005
2Pneumonia (Pneumonitis)
11/2005 - 05/2004
1Allergic Rhinitis
01/2022
1Gastroesophageal Reflux (GERD)
01/2022
1Genetic Risk Score
11/2021
1Symptom Flare Up
09/2021
1Hyperlipoproteinemias
01/2021
1Atherosclerosis
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Dyslipidemias (Dyslipidemia)
11/2020

Drug/Important Bio-Agent (IBA)

15LDL CholesterolIBA
01/2022 - 01/2016
12oxidized low density lipoproteinIBA
11/2021 - 05/2013
8LipidsIBA
01/2021 - 07/2018
7LDL Lipoproteins (beta Lipoproteins)IBA
01/2022 - 01/2016
4Adenosine Triphosphate (ATP)IBA
06/2022 - 09/2018
4omega-Chloroacetophenone (Mace)IBA
03/2021 - 12/2012
4Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2006
3Immunoglobulin E (IgE)IBA
01/2022 - 10/2005
3Phytosterols (Plant Sterols)IBA
08/2021 - 08/2018
3gamma-sitosterol (beta-sitosterol)IBA
08/2021 - 09/2018
3Biomarkers (Surrogate Marker)IBA
07/2021 - 12/2016
3Apolipoproteins B (ApoB)IBA
01/2021 - 01/2019
3SterolsIBA
10/2020 - 08/2018
3Triglycerides (Triacylglycerol)IBA
01/2019 - 01/2017
3Lipoproteins (Lipoprotein)IBA
01/2019 - 08/2018
3AllergensIBA
09/2015 - 10/2005
3Transcription Factors (Transcription Factor)IBA
07/2006 - 11/2005
3Peptide Hydrolases (Proteases)FDA Link
04/2006 - 11/2005
2CreatinineIBA
02/2022 - 08/2018
2LDL Receptors (LDL Receptor)IBA
03/2021 - 05/2020
2CholesterolIBA
03/2021 - 08/2018
2ApolipoproteinsIBA
01/2021 - 01/2019
2Ezetimibe (Zetia)FDA Link
12/2020 - 01/2020
2Peptides (Polypeptides)IBA
02/2020 - 01/2007
2Anaplastic Lymphoma KinaseIBA
02/2020 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
06/2019 - 05/2013
2AlbuminsIBA
06/2019 - 06/2005
2Interleukin-17 (Interleukin 17)IBA
11/2018 - 06/2017
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018 - 07/2018
2Dihydrotachysterol (AT 10)IBA
12/2012 - 03/2002
2Collagen Type I (Type I Collagen)IBA
01/2007 - 07/2004
2Transforming Growth Factor beta (TGF-beta)IBA
01/2007 - 07/2006
2Interleukin-13IBA
11/2006 - 10/2005
2Bleomycin (Blenoxane)FDA LinkGeneric
07/2006 - 05/2004
2AntioxidantsIBA
12/2005 - 11/2005
2alpha-galactosylceramideIBA
10/2005 - 05/2004
2LigandsIBA
10/2005 - 05/2004
2OvalbuminIBA
10/2005 - 03/2002
2CytokinesIBA
04/2005 - 05/2004
1Uric Acid (Urate)IBA
05/2022
1Hemoglobins (Hemoglobin)IBA
02/2022
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
02/2022
1Eplerenone (Inspra)FDA LinkGeneric
01/2022
1Mineralocorticoid Receptor AntagonistsIBA
01/2022
1Antihypertensive Agents (Antihypertensives)IBA
10/2021
1Therapeutic UsesIBA
05/2021
1alpha 1 Chain Collagen Type IIBA
05/2021
1fresolimumabIBA
05/2021
1alirocumabIBA
12/2020

Therapy/Procedure

14Therapeutics
10/2022 - 09/2013
5Percutaneous Coronary Intervention
05/2022 - 12/2012
2Precision Medicine
01/2021 - 10/2018
1Wearable Electronic Devices
09/2021
1Artificial Respiration (Mechanical Ventilation)
09/2021
1Extracorporeal Membrane Oxygenation
09/2021
1Transjugular Intrahepatic Portasystemic Shunt
08/2021